|
DE3841091A1
(de)
|
1988-12-07 |
1990-06-13 |
Behringwerke Ag |
Synthetische antigene, verfahren zu ihrer herstellung und ihre verwendung
|
|
CA2006700A1
(en)
|
1989-01-17 |
1990-07-17 |
Antonello Pessi |
Synthetic peptides and their use as universal carriers for the preparation of immunogenic conjugates suitable for the development of synthetic vaccines
|
|
IT1237764B
(it)
|
1989-11-10 |
1993-06-17 |
Eniricerche Spa |
Peptidi sintetici utili come carriers universali per la preparazione di coniugati immunogenici e loro impiego per lo sviluppo di vaccini sintetici.
|
|
US7252829B1
(en)
*
|
1998-06-17 |
2007-08-07 |
Idm Pharma, Inc. |
HLA binding peptides and their uses
|
|
IT1262896B
(it)
|
1992-03-06 |
1996-07-22 |
|
Composti coniugati formati da proteine heat shock (hsp) e oligo-poli- saccaridi, loro uso per la produzione di vaccini.
|
|
US5550214A
(en)
*
|
1994-02-10 |
1996-08-27 |
Brigham And Women's Hospital |
Isolated antigenic oncogene peptide fragments and uses
|
|
GB9713156D0
(en)
|
1997-06-20 |
1997-08-27 |
Microbiological Res Authority |
Vaccines
|
|
ATE459373T1
(de)
|
1999-03-19 |
2010-03-15 |
Glaxosmithkline Biolog Sa |
Impfstoff gegen kapsulare polysaccharide von streptococcus pneumoniae
|
|
JP2002541808A
(ja)
|
1999-04-09 |
2002-12-10 |
テクラブ， インコーポレイテッド |
ポリサッカリド結合体ワクチンのための組換えトキシンａタンパク質キャリア
|
|
ATE512666T1
(de)
|
1999-06-29 |
2011-07-15 |
Epimmune Inc |
Hla-bindende peptide und ihre verwendungen
|
|
EP1239866A4
(en)
*
|
1999-12-10 |
2005-02-09 |
Epimmune Inc |
INDUCTION OF HER2 / NEU CELLULAR IMMUNE RESPONSES USING PEPTIDE AND NUCLEIC ACID-CONTAINING COMPOSITIONS
|
|
WO2001058479A1
(en)
|
2000-02-08 |
2001-08-16 |
The Penn State Research Foundation |
Immunotherapy using interleukin 13 receptor subunit alpha 2
|
|
CA2400215A1
(en)
|
2000-02-23 |
2001-08-30 |
Epimmune Inc. |
Hla binding peptides and their uses
|
|
US7892559B2
(en)
|
2002-01-30 |
2011-02-22 |
Survac Aps |
Survivin-derived peptides and use thereof
|
|
WO2003092717A1
(en)
|
2002-03-22 |
2003-11-13 |
The Penn State Research Foundation |
Cancer immunotherapy
|
|
CA2500715A1
(en)
|
2002-10-03 |
2004-04-15 |
Epimmune Inc. |
Hla binding peptides and their uses
|
|
CN1954217B
(zh)
*
|
2004-02-06 |
2013-05-08 |
国立健康与医学研究所 |
衍生自gp41的多肽、含有所述多肽的疫苗组合物以及用于治疗个体HIV病毒感染的用途
|
|
US7612162B2
(en)
|
2004-09-21 |
2009-11-03 |
University Of Pittsburgh - Of The Commonwealth System Of Higher Education |
Peptide analogs capable of enhancing stimulation of a glioma-specific CTL response
|
|
US7666622B2
(en)
|
2005-10-19 |
2010-02-23 |
Regeneron Pharmaceuticals, Inc. |
Monomeric self-associating fusion polypeptides and therapeutic uses thereof
|
|
BRPI0720280A2
(pt)
|
2006-12-11 |
2014-01-28 |
Wyeth Corp |
Métodos e composições para tratar e monitorar tratamento de desordens associadas à il-13
|
|
JP2010190572A
(ja)
*
|
2007-06-01 |
2010-09-02 |
Sapporo Medical Univ |
ＩＬ１３Ｒａ２に対する抗体およびこれを含む診断・治療薬
|
|
BR122017025062B8
(pt)
|
2007-06-18 |
2021-07-27 |
Merck Sharp & Dohme |
anticorpo monoclonal ou fragmento de anticorpo para o receptor de morte programada humano pd-1, polinucleotídeo e composição compreendendo o referido anticorpo ou fragmento
|
|
US8569244B2
(en)
|
2007-08-20 |
2013-10-29 |
Oncotherapy Science, Inc. |
FOXM1 peptide and medicinal agent comprising the same
|
|
WO2010018136A1
(en)
*
|
2008-08-12 |
2010-02-18 |
Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A. |
Minigene comprising htpa signal peptide, t-cell epitopes, e. coli ltb and furin sensitive linkers
|
|
EP3255060A1
(en)
|
2008-12-09 |
2017-12-13 |
F. Hoffmann-La Roche AG |
Anti-pd-l1 antibodies and their use to enhance t-cell function
|
|
WO2010129033A2
(en)
*
|
2009-04-29 |
2010-11-11 |
Calmune Corporation |
Modified antibodies for passive immunotherapy
|
|
PL2504364T3
(pl)
|
2009-11-24 |
2017-12-29 |
Medimmune Limited |
Ukierunkowane środki wiążące przeciwko B7-H1
|
|
WO2011140284A2
(en)
|
2010-05-04 |
2011-11-10 |
Fred Hutchinson Cancer Research Center |
Conditional superagonist ctl ligands for the promotion of tumor-specific ctl responses
|
|
CA2809362C
(en)
|
2010-08-24 |
2020-03-10 |
University Of Pittsburgh - Of The Commonwealth System Of Higher Educatn |
Interleukin-13 receptor alpha 2 peptide-based brain cancer vaccines
|
|
EP2639299A1
(en)
|
2012-03-16 |
2013-09-18 |
Invectys |
Universal cancer peptides derived from telomerase
|
|
EP2828664B1
(en)
|
2012-03-19 |
2018-09-26 |
Stemline Therapeutics Inc. |
Methods for treating and monitoring the status of cancer
|
|
WO2013148147A1
(en)
|
2012-03-26 |
2013-10-03 |
The U.S.A., As Represented By The Secretary Dept. Of Health And Human Services |
Dna methylation analysis for the diagnosis, prognosis and treatment of adrenal neoplasms
|
|
CA3183703A1
(en)
|
2012-05-16 |
2013-11-21 |
Stemline Therapeutics, Inc. |
Cancer stem cell targeted cancer vaccines
|
|
US20140141044A1
(en)
*
|
2012-11-12 |
2014-05-22 |
Dana-Farber Cancer Institute, Inc. |
Cord Colitis Syndrome Pathogen
|
|
US9758807B2
(en)
|
2012-12-05 |
2017-09-12 |
SOLA Biosciences, LLC |
Protein expression enhancing polypeptides
|
|
WO2014088432A1
(en)
|
2012-12-06 |
2014-06-12 |
Callaghan Innovation Research Limited |
Conjugate compounds
|
|
KR20160016725A
(ko)
*
|
2014-08-05 |
2016-02-15 |
주식회사 유영제약 |
암 세포에 과발현되는 IL13Rα2에 특이적으로 결합하는 키메라 항원 수용체로 변형된 T 세포
|
|
WO2016133779A1
(en)
|
2015-02-16 |
2016-08-25 |
The Trustees Of The University Of Pennsylvania |
A fully-human t cell receptor specific for the 369-377 epitope derived from the her2/neu (erbb2) receptor protein
|
|
US20180133327A1
(en)
|
2015-03-16 |
2018-05-17 |
Amal Therapeutics Sa |
Cell Penetrating Peptides and Complexes Comprising the Same
|
|
US20180078627A1
(en)
*
|
2015-03-31 |
2018-03-22 |
Agency For Science, Technology And Research |
Method for antigen loading of dendritic cells and vaccine
|
|
US12018331B2
(en)
|
2016-05-23 |
2024-06-25 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Methods of diagnosing cancer using cancer testis antigens
|
|
WO2018065623A2
(en)
|
2016-10-07 |
2018-04-12 |
Enterome |
Immunogenic compounds for cancer therapy
|
|
CN110022894B
(zh)
|
2016-10-07 |
2024-01-19 |
恩特罗姆公司 |
用于癌症疗法的免疫原性化合物
|
|
WO2018065628A2
(en)
|
2016-10-07 |
2018-04-12 |
Enterome |
Microbiota sequence variants of tumor-related antigenic epitopes
|
|
KR102823291B1
(ko)
|
2017-10-09 |
2025-06-19 |
엔터롬 에스.에이. |
종양-관련된 항원 에피토프의 미생물 서열 변이체
|
|
US20210106652A1
(en)
|
2018-04-11 |
2021-04-15 |
Enterome S.A. |
Immunogenic Compounds For Treatment Of Fibrosis, Autoimmune Diseases And Inflammation
|
|
HRP20230007T1
(hr)
|
2018-04-11 |
2023-03-03 |
Enterome S.A. |
Antigenski peptidi, namijenjeni sprječavanju i liječenju raka
|
|
MX2022004598A
(es)
|
2019-10-16 |
2022-09-23 |
Enterome S A |
Compuestos inmunogenicos para el tratamiento del cancer suprarrenal.
|
|
FI4021487T3
(fi)
|
2019-11-15 |
2024-02-06 |
Enterome S A |
Antigeenisiä peptidejä b-solun pahanlaatuisuuden ehkäisyyn ja hoitoon
|